Utilisation Patterns and Real-World Effects of Tezacaftor and Ivacaftor Combination Therapy (TEZ/IVA) in Patients With Cystic Fibrosis (CF) First published 18/07/2019 Last updated 03/03/2025 EU PAS number:EUPAS30550 Study Finalised